We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Search Results

Showing 1-20 of 10,000 results
  1. Clinical and cost-effectiveness of ‘Live Well with Parkinson’s’ self-management intervention versus treatment as usual for improving quality of life for people with Parkinson’s: study protocol for a randomised controlled trial

    Background

    The Live Well with Parkinson’s Self-Management Toolkit is designed for use in the NHS to support people with Parkinson’s, their carers and...

    Kate Walters, Megan Armstrong, ... Anette Schrag in Trials
    Article Open access 05 December 2023
  2. Spirituality and Influencing Factors in Parkinson’s Disease: A Scoping Review

    Although the effect of spirituality in chronic disease has been discussed in recent years, little is known about spirituality and spiritual beliefs...

    Esra Çavuşoğlu, Abdullah Avcı in Journal of Religion and Health
    Article 02 December 2023
  3. Association of physical activity pattern and risk of Parkinson’s disease

    Increasing evidence suggests an association between exercise duration and Parkinson’s disease. However, no high-quality prospective evidence exists...

    Fabin Lin, Yixiang Lin, ... Guoen Cai in npj Digital Medicine
    Article Open access 23 May 2024
  4. The role of nurses for patients with Parkinson’s disease at home: a scoping review

    Background

    Parkinson’s disease is a neurodegenerative disease, and many patients are cared for at home by nurses. Parkinson’s disease nurse...

    Takako Fujita, Miho Iwaki, Yoko Hatono in BMC Nursing
    Article Open access 11 May 2024
  5. Optimal Protocol and Clinical Usefulness of 123I-MIBG Cardiac Scintigraphy for Differentiation of Parkinson’s Disease and Dementia with Lewy Body from Non-Parkinson’s Diseases

    Purpose

    123 I-metaiodobenzylguanidine (MIBG) cardiac scintigraphy was a useful imaging modality for the diagnosis of Parkinson’s disease, but its...

    Article 07 March 2023
  6. Dyspnea, the silent threat in Parkinson’s: a mixed methods study

    Background

    Dyspnea is considered a silent threat to people diagnosed with Parkinson’s disease and may be a common concern in patients, however, little...

    Aseel Aburub, Mohammad Z. Darabseh, ... Hanan Khalil in BMC Neurology
    Article Open access 01 July 2024
  7. Descriptive and inferential analysis of features for Dysphonia and Dysarthria Parkinson’s disease symptoms

    Parkinson’s disease is related to nervous system disorders in human beings. In this paper, the status of Parkinson’s disease has been predicted based...

    Saiyed Umer, Ranjeet Kumar Rout in Health Services and Outcomes Research Methodology
    Article 01 November 2023
  8. An Ethnographic Study of Patient Life Experience in Early-Stage Parkinson’s Disease in the United States and Germany

    Introduction

    Existing qualitative research on early-stage Parkinson’s disease draws on patients’ reported disease experience, aiming to capture the...

    Todd Carmody, Rebekah Park, ... Amelia Hursey in Neurology and Therapy
    Article Open access 12 June 2024
  9. What is available to support pain management in Parkinson’s: a scoping review protocol

    Objective

    A scoping review will be undertaken to examine and map the available evidence that has been produced in relation to pain management in...

    Mark Parkinson, Cormac Ryan, ... Jenni Naisby in International Journal for Equity in Health
    Article Open access 23 November 2023
  10. Validation of the Italian version of the Questionnaire for Impulsive-Compulsive Disorders in Parkinson’s Disease-Rating Scale (QUIP-RS) in an Italian Parkinson’s disease cohort

    Introduction

    Impulse control disorders (ICDs) frequently occur in Parkinson’s disease (PD), and an early identification is essential to prevent severe...

    Gianpaolo Maggi, Carmine Vitale, ... Gabriella Santangelo in Neurological Sciences
    Article Open access 17 January 2024
  11. Economic Burden of Parkinson’s Disease: A Multinational, Real-World, Cost-of-Illness Study

    Background

    Parkinson’s disease is now one of the fastest-growing neurodegenerative disorders in the developed world, with an increasing prevalence and...

    K. Ray Chaudhuri, Jean-Philippe Azulay, ... Pablo Martinez-Martin in Drugs - Real World Outcomes
    Article Open access 09 January 2024
  12. Does Parkinson’s disease affect sleep quality?

    Background

    Parkinson’s disease (PD) is a common neurodegenerative disease that is linked to several motor and nonmotor symptoms, including sleep...

    Hussein A. Hammadi, Woruod Ahmed Hameed, ... Laith Thamer Al-Ameri in Irish Journal of Medical Science (1971 -)
    Article 16 April 2024
  13. Parkinson’s Disease and Diabetes Mellitus: Synergistic Effects on Pathophysiology and GI Motility

    Purpose of Review

    Parkinson’s disease and diabetes affect an increasing proportion of the aging global population. Both conditions extensively affect...

    Yun Yan, Dhanush Shimoga, Amol Sharma in Current Gastroenterology Reports
    Article 17 April 2023
  14. Cognitive impairment and dementia in young onset Parkinson’s disease

    Background and objective

    Patients with young-onset Parkinson’s disease (YOPD) have a slower progression. Our aim was to analyze the change in...

    Diego Santos-García, Teresa de Deus Fonticoba, ... C. Villanueva in Journal of Neurology
    Article 14 August 2023
  15. Spirituality and Spiritual Distress in Parkinson’s Disease Caregivers: A Scoping Review

    Despite recognition that spiritual concerns contribute to caregiver burden, little is known about spirituality, spiritual well-being, and spiritual...

    Sandhya Seshadri, Kei Sugiura, ... Benzi M. Kluger in Journal of Religion and Health
    Article 13 September 2023
  16. Intervention components in the self-management of Parkinson’s: a mixed-methods synthesis of qualitative and quantitative evidence

    Introduction

    Self-management interventions consist of multiple components to support people in the management of medical, emotional, and behavioural...

    Megan Armstrong, Kate Walters, ... Anette Schrag in BMC Health Services Research
    Article Open access 17 January 2024
  17. Early onset Parkinson’s disease in the cycle of 3,4-methylenedioxymethamphetamine and substance use: a case report

    Background

    Current evidence linking the development of Parkinson’s disease after the use of 3,4-methylenedioxymethamphetamine is mixed and limited,...

    Tianyi Hui, Song Guo in Journal of Medical Case Reports
    Article Open access 23 September 2023
  18. Structural and Functional Imaging Correlates of Visual Hallucinations in Parkinson’s Disease

    Purpose of Review

    To review recent structural and functional MRI studies of visual hallucinations in Parkinson’s disease.

    Recent Findings ...
    Rohan Bhome, George Edward Calver Thomas, ... Rimona Sharon Weil in Current Neurology and Neuroscience Reports
    Article Open access 01 May 2023
  19. Using AI to measure Parkinson’s disease severity at home

    We present an artificial intelligence (AI) system to remotely assess the motor performance of individuals with Parkinson’s disease (PD). In our...

    Md Saiful Islam, Wasifur Rahman, ... Ehsan Hoque in npj Digital Medicine
    Article Open access 23 August 2023
  20. Constipation and pain in Parkinson’s disease: a clinical analysis

    Parkinson’s Disease (PD) is a neurodegenerative disorder characterized by both motor and non-motor symptoms (NMS). Among NMS, constipation and pain...

    Mohammad Al-Wardat, Piergiorgio Grillo, ... Silvia Natoli in Journal of Neural Transmission
    Article Open access 28 October 2023
Did you find what you were looking for? Share feedback.